LINDA L GERHARDT

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SAINT JOSEPH, MO NPI 1497051171

General Payments — all program years on this page

$597.30

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 35
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $377.11 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $377.1121

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $26.302
2023 $193.8912
2024 $377.1121

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089425285 Daiichi Sankyo Inc. $23.43 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100535269 Novo Nordisk Inc $14.24 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104685223 AstraZeneca Pharmaceuticals LP $14.86 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104749546 AstraZeneca Pharmaceuticals LP $30.89 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105670789 AstraZeneca Pharmaceuticals LP $14.65 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105866606 AstraZeneca Pharmaceuticals LP $14.64 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107164453 ABBVIE INC. $22.41 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107164455 ABBVIE INC. $13.90 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107164457 ABBVIE INC. $18.56 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107164459 ABBVIE INC. $18.09 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107164461 ABBVIE INC. $26.60 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114493458 Exact Sciences Corporation $18.23 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116268062 GlaxoSmithKline, LLC. $13.16 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116326192 GlaxoSmithKline, LLC. $16.93 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116430335 GlaxoSmithKline, LLC. $17.62 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131872203 PFIZER INC. $14.67 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135790096 Lilly USA, LLC $16.09 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136242251 SCILEX PHARMACEUTICALS INC. $13.93 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139543780 Astellas Pharma US Inc $18.89 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148962376 Sumitomo Pharma America, Inc. $16.14 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151168024 Phathom Pharmaceuticals, Inc. $19.18 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.